Literature DB >> 16801133

The duplicitous nature of the Lyn tyrosine kinase in growth factor signaling.

Margaret L Hibbs1, Kenneth W Harder.   

Abstract

The Lyn tyrosine kinase is a unique member of the Src family of non-receptor protein tyrosine kinases whose principal role is to regulate signals through inhibitory receptors thereby promoting signal attenuation. Lyn is renowned for its role in B cell antigen receptor and FcepsilonRI signaling; however, it is becoming increasingly apparent that Lyn also functions in signal transduction from growth factor receptors including the receptors for GM-CSF, IL-3, IL-5, SCF, erythropoietin, CSF-1, G-CSF, thrombopoietin and Flt3 ligand. Numerous studies have implicated Lyn in growth factor receptor signal amplification, while a number also suggest that Lyn participates in negative regulation of growth factor signaling. Indeed Lyn-deficient mice are hyper-responsive to myeloid growth factors and develop a myeloproliferative disorder that predisposes the mice to macrophage tumours, with loss of negative regulation through SHP-1 and SHIP-1 thought to be the major contributing factor to this phenotype. Developing a clear understanding of Lyn's role in establishing signaling thresholds in growth factor receptor signal amplification and signal inhibition may have important implications in the management of leukemias that may depend on Lyn activity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16801133     DOI: 10.1080/08977190600581327

Source DB:  PubMed          Journal:  Growth Factors        ISSN: 0897-7194            Impact factor:   2.511


  15 in total

1.  Deficiency of Src family kinases compromises the repopulating ability of hematopoietic stem cells.

Authors:  Christie M Orschell; Jovencio Borneo; Veerendra Munugalavadla; Peilin Ma; Emily Sims; Baskar Ramdas; Mervin C Yoder; Reuben Kapur
Journal:  Exp Hematol       Date:  2008-03-17       Impact factor: 3.084

Review 2.  The diverse functions of Src family kinases in macrophages.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  Front Biosci       Date:  2008-05-01

3.  Constitutive activation of Lyn kinase enhances BCR responsiveness, but not the development of CLL in Eµ-TCL1 mice.

Authors:  Viktoria Kohlhas; Michael Hallek; Phuong-Hien Nguyen
Journal:  Blood Adv       Date:  2020-12-22

Review 4.  Basophils and autoreactive IgE in the pathogenesis of systemic lupus erythematosus.

Authors:  Nicolas Charles; Juan Rivera
Journal:  Curr Allergy Asthma Rep       Date:  2011-10       Impact factor: 4.806

5.  Alternative modes of GM-CSF receptor activation revealed using activated mutants of the common beta-subunit.

Authors:  Michelle Perugini; Anna L Brown; Diana G Salerno; Grant W Booker; Cvetan Stojkoski; Timothy R Hercus; Angel F Lopez; Margaret L Hibbs; Thomas J Gonda; Richard J D'Andrea
Journal:  Blood       Date:  2010-02-19       Impact factor: 22.113

Review 6.  Multiple roles of Lyn kinase in myeloid cell signaling and function.

Authors:  Patrizia Scapini; Shalini Pereira; Hong Zhang; Clifford A Lowell
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

7.  Association between imatinib-resistant BCR-ABL mutation-negative leukemia and persistent activation of LYN kinase.

Authors:  Ji Wu; Feng Meng; Ling-Yuan Kong; Zhenghong Peng; Yunming Ying; William G Bornmann; Bryant G Darnay; Betty Lamothe; Hanshi Sun; Moshe Talpaz; Nicholas J Donato
Journal:  J Natl Cancer Inst       Date:  2008-06-24       Impact factor: 13.506

Review 8.  Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease.

Authors:  Valerie I Brown; Alix E Seif; Gregor S D Reid; David T Teachey; Stephan A Grupp
Journal:  Immunol Res       Date:  2008       Impact factor: 2.829

9.  Targeting Lyn inhibits tumor growth and metastasis in Ewing's sarcoma.

Authors:  Hui Guan; Zhichao Zhou; Gary E Gallick; Shu-Fang Jia; Jaime Morales; Anil K Sood; Seth J Corey; Eugenie S Kleinerman
Journal:  Mol Cancer Ther       Date:  2008-07       Impact factor: 6.261

10.  CD72 negatively regulates KIT-mediated responses in human mast cells.

Authors:  Tatsuki R Kataoka; Atsushi Kumanogoh; Geethani Bandara; Dean D Metcalfe; Alasdair M Gilfillan
Journal:  J Immunol       Date:  2010-01-25       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.